SoftOx Solutions AS (SOFTX) - Total Liabilities
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has total liabilities worth Nkr17.26 Million NOK (≈ $1.82 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SoftOx Solutions AS cash flow conversion to assess how effectively this company generates cash.
SoftOx Solutions AS - Total Liabilities Trend (2016–2024)
This chart illustrates how SoftOx Solutions AS's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of SoftOx Solutions AS to evaluate the company's liquid asset resilience ratio.
SoftOx Solutions AS Competitors by Total Liabilities
The table below lists competitors of SoftOx Solutions AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
nTels Co. Ltd
KQ:069410
|
Korea | ₩12.49 Billion |
|
AQUA SA ZY 16
F:9S0
|
Germany | €150.40 Million |
|
Lung Hwa Electronics Co Ltd
TW:2424
|
Taiwan | NT$145.44 Million |
|
Mindax Ltd
AU:MDX
|
Australia | AU$1.90 Million |
|
Kein Hing International Bhd
KLSE:7199
|
Malaysia | RM99.26 Million |
|
9F Inc
NASDAQ:JFU
|
USA | $537.09 Million |
|
Senetas Corporation Ltd
AU:SEN
|
Australia | AU$16.74 Million |
|
Next Science Ltd
AU:NXS
|
Australia | AU$10.02 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down SoftOx Solutions AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of SoftOx Solutions AS.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SoftOx Solutions AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SoftOx Solutions AS (2016–2024)
The table below shows the annual total liabilities of SoftOx Solutions AS from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr25.96 Million ≈ $2.73 Million |
-72.64% |
| 2023-12-31 | Nkr94.87 Million ≈ $9.98 Million |
+53.45% |
| 2022-12-31 | Nkr61.83 Million ≈ $6.51 Million |
+237.34% |
| 2021-12-31 | Nkr18.33 Million ≈ $1.93 Million |
+65.23% |
| 2020-12-31 | Nkr11.09 Million ≈ $1.17 Million |
-40.03% |
| 2019-12-31 | Nkr18.50 Million ≈ $1.95 Million |
+105.86% |
| 2018-12-31 | Nkr8.98 Million ≈ $945.45K |
+114.38% |
| 2017-12-31 | Nkr4.19 Million ≈ $441.01K |
-34.30% |
| 2016-12-31 | Nkr6.38 Million ≈ $671.23K |
-- |
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more